Mesenchymal stem cells and their role in tumor progression

Cancer Stem Cells

Volumn , Issue , 2010, Pages 63-75

  Dittmer, Jürgen ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79960028990     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (94)

1. Friedenstein, A. J., Piatetzky, S., II & Petrakova, K. V. (1966) Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol, 16, 381-390.
2. Friedenstein, A. & Kuralesova, A. I. (1971) Osteogenic precursor cells of bone marrow in radiation chimeras. Transplantation, 12, 99-108.
3. Caplan, A. I. (1991) Mesenchymal stem cells. J Orthop Res., 9, 641-650.
4. Friedenstein, A. J., Chailakhyan, R. K., Latsinik, N. V., Panasyuk, A. F. & Keiliss-Borok, I. V. (1974) Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation, 17, 331-340.
5. Wexler, S. A., Donaldson, C., Denning-Kendall, P., Rice, C., Bradley, B. & Hows, J. M. (2003) Adult bone marrow is a rich source of human mesenchymal 'stem' cells but umbilical cord and mobilized adult blood are not. Br J Haematol, 121, 368-374.
6. Phinney, D. G. (2002) Building a consensus regarding the nature and origin of mesenchymal stem cells. J Cell Biochem Suppl, 38, 7-12.
7. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., Deans, R., Keating, A., Prockop, D. & Horwitz, E. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8, 315-317.
8. Beyer Nardi, N. & da Silva Meirelles, L. (2006) Mesenchymal stem cells: isolation, in vitro expansion and characterization. Handb Exp Pharmacol, 249-282.
9. Zuk, P. A., Zhu, M., Mizuno, H., Huang, J., Futrell, J. W., Katz, A. J., Benhaim, P., Lorenz, H. P. & Hedrick, M. H. (2001) Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng, 7, 211-228.
10. Crisan, M., Yap, S., Casteilla, L., Chen, C. W., Corselli, M., Park, T. S., Andriolo, G., Sun, B., Zheng, B., Zhang, L., Norotte, C., Teng, P. N., Traas, J., Schugar, R., Deasy, B. M., Badylak, S., Buhring, H. J., Giacobino, J. P., Lazzari, L., Huard, J. & Peault, B. (2008) A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell, 3, 301-313.
11. Uccelli, A., Moretta, L. & Pistoia, V. (2008) Mesenchymal stem cells in health and disease. Nat Rev Immunol, 8, 726-736.
12. Jiang, X. X., Zhang, Y., Liu, B., Zhang, S. X., Wu, Y., Yu, X. D. & Mao, N. (2005) Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood, 105, 4120-4126.
13. Ramasamy, R., Fazekasova, H., Lam, E. W., Soeiro, I., Lombardi, G. & Dazzi, F. (2007) Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle. Transplantation, 83, 71-76.
14. Aggarwal, S. & Pittenger, M. F. (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood, 105, 1815-1822.
15. Beyth, S., Borovsky, Z., Mevorach, D., Liebergall, M., Gazit, Z., Aslan, H., Galun, E. & Rachmilewitz, J. (2005) Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood, 105, 2214-2219.
16. Bartholomew, A., Sturgeon, C., Siatskas, M., Ferrer, K., McIntosh, K., Patil, S., Hardy, W., Devine, S., Ucker, D., Deans, R., Moseley, A. & Hoffman, R. (2002) Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol, 30, 42-48.
17. Di Nicola, M., Carlo-Stella, C., Magni, M., Milanesi, M., Longoni, P. D., Matteucci, P., Grisanti, S. & Gianni, A. M. (2002) Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood, 99, 3838-3843.
18. Rasmusson, I., Ringden, O., Sundberg, B. & Le Blanc, K. (2005) Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. Exp Cell Res, 305, 33-41.
19. Krampera, M., Glennie, S., Dyson, J., Scott, D., Laylor, R., Simpson, E. & Dazzi, F. (2003) Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood, 101, 3722-3729.
20. Glennie, S., Soeiro, I., Dyson, P. J., Lam, E. W. & Dazzi, F. (2005) Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood, 105, 2821-2827.
21. Selmani, Z., Naji, A., Zidi, I., Favier, B., Gaiffe, E., Obert, L., Borg, C., Saas, P., Tiberghien, P., Rouas-Freiss, N., Carosella, E. D. & Deschaseaux, F. (2008) Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells. Stem Cells, 26, 212-222.
22. Rasmusson, I., Ringden, O., Sundberg, B. & Le Blanc, K. (2003) Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation, 76, 1208-1213.
23. Spaggiari, G. M., Capobianco, A., Abdelrazik, H., Becchetti, F., Mingari, M. C. & Moretta, L. (2008) Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood, 111, 1327-1333.
24. Sotiropoulou, P. A., Perez, S. A., Gritzapis, A. D., Baxevanis, C. N. & Papamichail, M. (2006) Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells, 24, 74-85.
25. Spaggiari, G. M., Capobianco, A., Becchetti, S., Mingari, M. C. & Moretta, L. (2006) Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood, 107, 1484-1490.
26. Raffaghello, L., Bianchi, G., Bertolotto, M., Montecucco, F., Busca, A., Dallegri, F., Ottonello, L. & Pistoia, V. (2008) Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche. Stem Cells, 26, 151-162.
27. Campioni, D., Lanza, F., Moretti, S., Ferrari, L. & Cuneo, A. (2008) Loss of Thy-1 (CD90) antigen expression on mesenchymal stromal cells from hematologic malignancies is induced by in vitro angiogenic stimuli and is associated with peculiar functional and phenotypic characteristics. Cytotherapy, 10, 69-82.
28. Campioni, D., Rizzo, R., Stignani, M., Melchiorri, L., Ferrari, L., Moretti, S., Russo, A., Bagnara, G. P., Bonsi, L., Alviano, F., Lanzoni, G., Cuneo, A., Baricordi, O. R. & Lanza, F. (2009) A decreased positivity for CD90 on human mesenchymal stromal cells (MSCs) is associated with a loss of immunosuppressive activity by MSCs. Cytometry B Clin Cytom, 76, 225-230.
29. Corcione, A., Benvenuto, F., Ferretti, E., Giunti, D., Cappiello, V., Cazzanti, F., Risso, M., Gualandi, F., Mancardi, G. L., Pistoia, V. & Uccelli, A. (2006) Human mesenchymal stem cells modulate B-cell functions. Blood, 107, 367-372.
30. Traggiai, E., Volpi, S., Schena, F., Gattorno, M., Ferlito, F., Moretta, L. & Martini, A. (2008) Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients. Stem Cells, 26, 562-569.
31. Brooke, G., Cook, M., Blair, C., Han, R., Heazlewood, C., Jones, B., Kambouris, M., Kollar, K., McTaggart, S., Pelekanos, R., Rice, A., Rossetti, T. & Atkinson, K. (2007) Therapeutic applications of mesenchymal stromal cells. Semin Cell Dev Biol, 18, 846-858.
32. Rojas, M., Xu, J., Woods, C. R., Mora, A. L., Spears, W., Roman, J. & Brigham, K. L. (2005) Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol, 33, 145-152.
33. Natsu, K., Ochi, M., Mochizuki, Y., Hachisuka, H., Yanada, S. & Yasunaga, Y. (2004) Allogeneic bone marrow-derived mesenchymal stromal cells promote the regeneration of injured skeletal muscle without differentiation into myofibers. Tissue Eng, 10, 1093-1112.
34. Kurozumi, K., Nakamura, K., Tamiya, T., Kawano, Y., Kobune, M., Hirai, S., Uchida, H., Sasaki, K., Ito, Y., Kato, K., Honmou, O., Houkin, K., Date, I. & Hamada, H. (2004) BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model. Mol Ther, 9, 189-197.
35. Barbash, I. M., Chouraqui, P., Baron, J., Feinberg, M. S., Etzion, S., Tessone, A., Miller, L., Guetta, E., Zipori, D., Kedes, L. H., Kloner, R. A. & Leor, J. (2003) Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation, 108, 863-868.
36. Mahmood, A., Lu, D., Lu, M. & Chopp, M. (2003) Treatment of traumatic brain injury in adult rats with intravenous administration of human bone marrow stromal cells. Neurosurgery, 53, 697-702.
37. Wu, G. D., Nolta, J. A., Jin, Y. S., Barr, M. L., Yu, H., Starnes, V. A. & Cramer, D. V. (2003) Migration of mesenchymal stem cells to heart allografts during chronic rejection. Transplantation, 75, 679-685.
38. Kidd, S., Spaeth, E., Dembinski, J. L., Dietrich, M., Watson, K., Klopp, A., Battula, V. L., Weil, M., Andreeff, M. & Marini, F. C. (2009) Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging. Stem Cells, 27, 2614-2623.
39. Ortiz, L. A., Gambelli, F., McBride, C., Gaupp, D., Baddoo, M., Kaminski, N. & Phinney, D. G. (2003) Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci U S A, 100, 8407-8411.
40. Chen, J., Li, Y., Wang, L., Zhang, Z., Lu, D., Lu, M. & Chopp, M. (2001) Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke, 32, 1005-1011.
41. Park, K. S., Jung, K. H., Kim, S. H., Kim, K. S., Choi, M. R., Kim, Y. & Chai, Y. G. (2007) Functional expression of ion channels in mesenchymal stem cells derived from umbilical cord vein. Stem Cells, 25, 2044-2052.
42. Li, G. R., Sun, H., Deng, X. & Lau, C. P. (2005) Characterization of ionic currents in human mesenchymal stem cells from bone marrow. Stem Cells, 23, 371-38.
43. Tondreau, T., Lagneaux, L., Dejeneffe, M., Massy, M., Mortier, C., Delforge, A. & Bron, D. (2004) Bone marrow-derived mesenchymal stem cells already express specific neural proteins before any differentiation. Differentiation, 72, 319-326.
44. Krabbe, C., Zimmer, J. & Meyer, M. (2005) Neural transdifferentiation of mesenchymal stem cells--a critical review. Apmis, 113, 831-844.
45. Wislet-Gendebien, S., Hans, G., Leprince, P., Rigo, J. M., Moonen, G. & Rogister, B. (2005) Plasticity of cultured mesenchymal stem cells: switch from nestin-positive to excitable neuron-like phenotype. Stem Cells, 23, 392-402.
46. Toma, C., Pittenger, M. F., Cahill, K. S., Byrne, B. J. & Kessler, P. D. (2002) Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation, 105, 93-98.
47. Wang, J. S., Shum-Tim, D., Chedrawy, E. & Chiu, R. C. (2001) The coronary delivery of marrow stromal cells for myocardial regeneration: pathophysiologic and therapeutic implications. J Thorac Cardiovasc Surg, 122, 699-705.
48. Ito, T., Suzuki, A., Imai, E., Okabe, M. & Hori, M. (2001) Bone marrow is a reservoir of repopulating mesangial cells during glomerular remodeling. J Am Soc Nephrol, 12, 2625-2635.
49. Lin, F., Cordes, K., Li, L., Hood, L., Couser, W. G., Shankland, S. J. & Igarashi, P. (2003) Hematopoietic stem cells contribute to the regeneration of renal tubules after renal ischemia-reperfusion injury in mice. J Am Soc Nephrol, 14, 1188-1199.
50. Kale, S., Karihaloo, A., Clark, P. R., Kashgarian, M., Krause, D. S. & Cantley, L. G. (2003) Bone marrow stem cells contribute to repair of the ischemically injured renal tubule. J Clin Invest, 112, 42-49.
51. Lee, R. H., Seo, M. J., Reger, R. L., Spees, J. L., Pulin, A. A., Olson, S. D. & Prockop, D. J. (2006) Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci U S A, 103, 17438-17443.
52. Hess, D., Li, L., Martin, M., Sakano, S., Hill, D., Strutt, B., Thyssen, S., Gray, D. A. & Bhatia, M. (2003) Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol, 21, 763-770.
53. Phinney, D. G. & Isakova, I. (2005) Plasticity and therapeutic potential of mesenchymal stem cells in the nervous system. Curr Pharm Des, 11, 1255-1265.
54. Amado, L. C., Saliaris, A. P., Schuleri, K. H., St John, M., Xie, J. S., Cattaneo, S., Durand, D. J., Fitton, T., Kuang, J. Q., Stewart, G., Lehrke, S., Baumgartner, W. W., Martin, B. J., Heldman, A. W. & Hare, J. M. (2005) Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A, 102, 11474-11479.
55. Itescu, S., Schuster, M. D. & Kocher, A. A. (2003) New directions in strategies using cell therapy for heart disease. J Mol Med, 81, 288-296.
56. Xu, J., Lu, Y., Ding, F., Zhan, X., Zhu, M. & Wang, Z. (2007) Reversal of diabetes in mice by intrahepatic injection of bone-derived GFP-murine mesenchymal stem cells infected with the recombinant retrovirus-carrying human insulin gene. World J Surg, 31, 1872-1882.
57. Rosland, G. V., Svendsen, A., Torsvik, A., Sobala, E., McCormack, E., Immervoll, H., Mysliwietz, J., Tonn, J. C., Goldbrunner, R., Lonning, P. E., Bjerkvig, R. & Schichor, C. (2009) Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Cancer Res, 69, 5331-5339.
58. Burns, J. S., Abdallah, B. M., Schroder, H. D. & Kassem, M. (2008) The histopathology of a human mesenchymal stem cell experimental tumor model: support for an hMSC origin for Ewing's sarcoma? Histol Histopathol, 23, 1229-1240.
59. Li, N., Yang, R., Zhang, W., Dorfman, H., Rao, P. & Gorlick, R. (2009) Genetically transforming human mesenchymal stem cells to sarcomas: changes in cellular phenotype and multilineage differentiation potential. Cancer, 115, 4795-4806.
60. Riggi, N., Suva, M. L., Suva, D., Cironi, L., Provero, P., Tercier, S., Joseph, J. M., Stehle, J. C., Baumer, K., Kindler, V. & Stamenkovic, I. (2008) EWS-FLI-1 expression triggers a Ewing's sarcoma initiation program in primary human mesenchymal stem cells. Cancer Res, 68, 2176-2185.
61. Studeny, M., Marini, F. C., Champlin, R. E., Zompetta, C., Fidler, I. J. & Andreeff, M. (2002) Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res, 62, 3603-3608.
62. Xin, H., Kanehira, M., Mizuguchi, H., Hayakawa, T., Kikuchi, T., Nukiwa, T. & Saijo, Y. (2007) Targeted delivery of CX3CL1 to multiple lung tumors by mesenchymal stem cells. Stem Cells, 25, 1618-1626.
63. Dvorak, H. F. (1986) Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med, 315, 1650-1659.
64. Kidd, S., Spaeth, E., Klopp, A., Andreeff, M., Hall, B. & Marini, F. C. (2008) The (in) auspicious role of mesenchymal stromal cells in cancer: be it friend or foe. Cytotherapy, 10, 657-667.
65. Ishii, G., Sangai, T., Oda, T., Aoyagi, Y., Hasebe, T., Kanomata, N., Endoh, Y., Okumura, C., Okuhara, Y., Magae, J., Emura, M., Ochiya, T. & Ochiai, A. (2003) Bone-marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction. Biochem Biophys Res Commun, 309, 232-240.
66. Direkze, N. C., Hodivala-Dilke, K., Jeffery, R., Hunt, T., Poulsom, R., Oukrif, D., Alison, M. R. & Wright, N. A. (2004) Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. Cancer Res, 64, 8492-8495.
67. Luetzkendorf, J., Mueller, L. P., Mueller, T., Caysa, H., Nerger, K. & Schmoll, H. J. (2009) Growth-inhibition of colorectal carcinoma by lentiviral TRAIL-transgenic human mesenchymal stem cells requires their substantial intratumoral presence. J Cell Mol Med, Epub ahead of print.
68. Menon, L. G., Kelly, K., Yang, H. W., Kim, S. K., Black, P. M. & Carroll, R. S. (2009) Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy. Stem Cells, 27, 2320-2330.
69. Nakamura, K., Ito, Y., Kawano, Y., Kurozumi, K., Kobune, M., Tsuda, H., Bizen, A., Honmou, O., Niitsu, Y. & Hamada, H. (2004) Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther, 11, 1155-1164.
70. Fritz, V., Noel, D., Bouquet, C., Opolon, P., Voide, R., Apparailly, F., Louis-Plence, P., Bouffi, C., Drissi, H., Xie, C., Perricaudet, M., Muller, R., Schwarz, E. & Jorgensen, C. (2008) Antitumoral activity and osteogenic potential of mesenchymal stem cells expressing the urokinase-type plasminogen antagonist amino-terminal fragment in a murine model of osteolytic tumor. Stem Cells, 26, 2981-2990.
71. Yong, R. L., Shinojima, N., Fueyo, J., Gumin, J., Vecil, G. G., Marini, F. C., Bogler, O., Andreeff, M. & Lang, F. F. (2009) Human bone marrow-derived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Delta24-RGD to human gliomas. Cancer Res, 69, 8932-8940.
72. Sonabend, A. M., Ulasov, I. V., Tyler, M. A., Rivera, A. A., Mathis, J. M. & Lesniak, M. S. (2008) Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma. Stem Cells, 26, 831-841.
73. You, M. H., Kim, W. J., Shim, W., Lee, S. R., Lee, G., Choi, S., Kim, D. Y., Kim, Y. M., Kim, H. & Han, S. U. (2009) Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model. J Gastroenterol Hepatol, 24, 1393-1400.
74. Parekkadan, B., van Poll, D., Suganuma, K., Carter, E. A., Berthiaume, F., Tilles, A. W. & Yarmush, M. L. (2007) Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PLoS On., 2, e941.
75. Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R. & Weinberg, R. A. (2007) Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature, 449, 557-563.
76. Dittmer, A., Hohlfeld, K., Lutzkendorf, J., Muller, L. P. & Dittmer, J. (2009) Human mesenchymal stem cells induce E-cadherin degradation in breast carcinoma spheroids by activating ADAM10. Cell Mol Life Sci, 66, 3053-3065.
77. Hombauer, H. & Minguell, J. J. (2000). Selective interactions between epithelial tumour cells and bone marrow mesenchymal stem cells. Br J Cancer, 82, 1290-1296.
78. Fierro, F. A., Sierralta, W. D., Epunan, M. J. & Minguell, J. J. (2004) Marrow-derived mesenchymal stem cells: role in epithelial tumor cell determination. Clin Exp Metastasis, 21, 313-319.
79. Rhodes, L. V., Muir, S. E., Elliott, S., Guillot, L. M., Antoon, J. W., Penfornis, P., Tilghman, S. L., Salvo, V. A., Fonseca, J. P., Lacey, M. R., Beckman, B. S., McLachlan, J. A., Rowan, B. G., Pochampally, R. & Burow, M. E. (2009) Adult human mesenchymal stem cells enhance breast tumorigenesis and promote hormone independence. Breast Cancer Res Treat, Epub ahead of print.
80. Sasser, A. K., Mundy, B. L., Smith, K. M., Studebaker, A. W., Axel, A. E., Haidet, A. M., Fernandez, S. A. & Hall, B. M. (2007) Human bone marrow stromal cells enhance breast cancer cell growth rates in a cell line-dependent manner when evaluated in 3D tumor environments. Cancer Lett, 254, 255-264.
81. Yu, J. M., Jun, E. S., Bae, Y. C. & Jung, J. S. (2008) Mesenchymal stem cells derived from human adipose tissues favor tumor cell growth in vivo. Stem Cells De., 17, 463-473.
82. Djouad, F., Plence, P., Bony, C., Tropel, P., Apparailly, F., Sany, J., Noel, D. & Jorgensen, C. (2003) Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood, 102, 3837-3844.
83. Djouad, F., Bony, C., Apparailly, F., Louis-Plence, P., Jorgensen, C. & Noel, D. (2006) Earlier onset of syngeneic tumors in the presence of mesenchymal stem cells. Transplantation, 82, 1060-1066.
84. Maestroni, G. J., Hertens, E. & Galli, P. (1999) Factor(s) from nonmacrophage bone marrow stromal cells inhibit Lewis lung carcinoma and B16 melanoma growth in mice. Cell Mol Life Sci, 55, 663-667.
85. Ohlsson, L. B., Varas, L., Kjellman, C., Edvardsen, K. & Lindvall, M. (2003) Mesenchymal progenitor cell-mediated inhibition of tumor growth in vivo and in vitro in gelatin matrix. Exp Mol Pathol, 75, 248-255.
86. Khakoo, A. Y., Pati, S., Anderson, S. A., Reid, W., Elshal, M. F., Rovira, II, Nguyen, A. T., Malide, D., Combs, C. A., Hall, G., Zhang, J., Raffeld, M., Rogers, T. B., Stetler-Stevenson, W., Frank, J. A., Reitz, M. & Finkel, T. (2006) Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J Exp Med, 203, 1235-1247
87. Qiao, L., Xu, Z., Zhao, T., Zhao, Z., Shi, M., Zhao, R. C., Ye, L. & Zhang, X. (2008) Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model. Cell Res, 18, 500-507.
88. Lin, S. Y., Yang, J., Everett, A. D., Clevenger, C. V., Koneru, M., Mishra, P. J., Kamen, B., Banerjee, D. & Glod, J. (2008) The isolation of novel mesenchymal stromal cell chemotactic factors from the conditioned medium of tumor cells. Exp Cell Res, 314, 3107-3117.
89. Dwyer, R. M., Potter-Beirne, S. M., Harrington, K. A., Lowery, A. J., Hennessy, E., Murphy, J. M., Barry, F. P., O'Brien, T. & Kerin, M. J. (2007) Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells. Clin Cancer Res, 13, 5020-5027.
90. Menon, L. G., Picinich, S., Koneru, R., Gao, H., Lin, S. Y., Koneru, M., Mayer-Kuckuk, P., Glod, J. & Banerjee, D. (2007) Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells. Stem Cells, 25, 520-528.
91. Mishra, P. J., Humeniuk, R., Medina, D. J., Alexe, G., Mesirov, J. P., Ganesan, S., Glod, J. W. & Banerjee, D. (2008) Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res, 68, 4331-4339.
92. Levina, V., Marrangoni, A. M., DeMarco, R., Gorelik, E. & Lokshin, A. E. (2008) Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties. PLoS One, 3, e3077.
93. Mueller, L. P., Luetzkendorf, J., Mueller, T., Reichelt, K., Simon, H. & Schmoll, H. J. (2006) Presence of mesenchymal stem cells in human bone marrow after exposure to chemotherapy: evidence of resistance to apoptosis induction. Stem Cell, 24, 2753-2765.
94. Jorgensen, C. (2009) Link between cancer stem cells and adult mesenchymal stromal cells: implications for cancer therapy. Regen Med, 4, 149-152.